Olivier Cabaud

2.4k total citations · 2 hit papers
19 papers, 1.7k citations indexed

About

Olivier Cabaud is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Olivier Cabaud has authored 19 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Immunology and 5 papers in Oncology. Recurrent topics in Olivier Cabaud's work include Immune Cell Function and Interaction (3 papers), Cancer Cells and Metastasis (3 papers) and T-cell and B-cell Immunology (3 papers). Olivier Cabaud is often cited by papers focused on Immune Cell Function and Interaction (3 papers), Cancer Cells and Metastasis (3 papers) and T-cell and B-cell Immunology (3 papers). Olivier Cabaud collaborates with scholars based in France, United States and Austria. Olivier Cabaud's co-authors include Daniel Birnbaum, Christophe Ginestier, Emmanuelle Charafe‐Jauffret, Julien Wicinski, Ming Luo, Gabriela Dontu, Jun-Lin Guan, Mark E. Diebel, Hasan Körkaya and Max S. Wicha and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Olivier Cabaud

19 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

2010 588 citations Christophe Ginestier, Suling Liu et al. Journal of Clinical Investigation profile →
Salinomycin kills cancer stem cells by sequestering iron in lysosomes

2017 465 citations Trang Thi, Ahmed Hamaï et al. Nature Chemistry profile →

Peers

Countries citing papers authored by Olivier Cabaud

Since Specialization

Citations

This map shows the geographic impact of Olivier Cabaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Cabaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Cabaud more than expected).

Fields of papers citing papers by Olivier Cabaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Cabaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Cabaud. The network helps show where Olivier Cabaud may publish in the future.

Co-authorship network of co-authors of Olivier Cabaud

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Cabaud. A scholar is included among the top collaborators of Olivier Cabaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Cabaud. Olivier Cabaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma 2023 ·Cancers ·David Jérémie Birnbaum, (unknown), (unknown), (unknown), Pascal Finetti, Olivier Cabaud, (unknown), (unknown), Emilie Denicolaï, François Bertucci, Émilie Mamessier	4
2	Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients 2022 ·Cancers ·Alexia Lopresti, Claire Acquaviva, Laurys Boudin, Pascal Finetti, Séverine Garnier, Anaïs Aulas, (unknown), Olivier Cabaud, Arnaud Guillé, Alexandre de Nonneville, (unknown), Emilie Denicolaï, Jihane Pakradouni, Anthony Gonçalvès, Daniel Birnbaum, François Bertucci, Émilie Mamessier	6
3	EFA6B regulates a stop signal for collective invasion in breast cancer 2021 ·Nature Communications ·(unknown), (unknown), Mariagrazia Partisani, Pascal Finetti, (unknown), Sophie Abélanet, Virginie Virolle, (unknown), Olivier Cabaud, Marc Lopez, Daniel Birnbaum, François Bertucci, Michel Franco, Frédéric Luton	5
4	Mutation of FOP/FGFR1OP in mice recapitulates human short rib-polydactyly ciliopathy 2018 ·Human Molecular Genetics ·Olivier Cabaud, Régine Roubin, (unknown), (unknown), Arnauld Sergé, (unknown), Daniel Birnbaum, Olivier Rosnet, Claire Acquaviva	6
5	Salinomycin kills cancer stem cells by sequestering iron in lysosomes breakdown → 2017 ·Nature Chemistry ·Trang Thi, Ahmed Hamaï, Antje Hienzsch, Tatiana Cañeque, Sebastian Müller, Julien Wicinski, Olivier Cabaud, Christine Le Roy, Amandine David, (unknown), Akihide Ryo, Christophe Ginestier, Daniel Birnbaum, Emmanuelle Charafe‐Jauffret, Patrice Codogno, Maryam Mehrpour, Raphaël Rodriguez	465
6	miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling 2017 ·Cell Reports ·(unknown), Guillaume Pinna, Olivier Cabaud, Julien Wicinski, (unknown), Laurent Guyon, (unknown), Pascal Finetti, (unknown), Bernard Mari, Pascal Barbry, François Bertucci, Ghislain Bidaut, Annick Harel‐Bellan, Daniel Birnbaum, Emmanuelle Charafe‐Jauffret, Christophe Ginestier	108
7	Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer 2016 ·Annals of Oncology ·(unknown), Olivier Cabaud, Emmanuelle Josselin, Pascal Finetti, Ronald K. Castellano, (unknown), (unknown), (unknown), Yves Collette, Patrice Viens, Ana Sofia Gonçalves, Christophe Ginestier, Emmanuelle Charafe‐Jauffret, Daniel Birnbaum, Daniel Olive, François Bertucci, Marc Lopez	103
8	EFA6B Antagonizes Breast Cancer 2014 ·Cancer Research ·Joséphine Zangari, Mariagrazia Partisani, François Bertucci, Julie Milanini, Ghislain Bidaut, Carole Berruyer-Pouyet, Pascal Finetti, Élodie Long-Mira, Frédéric Brau, Olivier Cabaud, Bruno Chetaille, Daniel Birnbaum, Marc Lopez, Paul Hofman, Michel Franco, Frédéric Luton	21
9	The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression 2013 ·Clinical Cancer Research ·(unknown), Julien Wicinski, Olivier Cabaud, Yves Toiron, Pascal Finetti, Emmanuelle Josselin, Hélène Lelièvre, Laurence Kraus‐Berthier, Stéphane Depil, François Bertucci, Yves Collette, Daniel Birnbaum, Emmanuelle Charafe‐Jauffret, Christophe Ginestier	113
10	Abstract 244: Cancer stem cells predict engraftment and poor prognosis of primary breast tumor. 2013 ·Cancer Research ·Emmanuelle Charafe‐Jauffret, Christophe Ginestier, François Bertucci, Olivier Cabaud, José Adélaı̈de, Max Chaffanet, Luc Xerri, Patrice Viens, Daniel Birnbaum	2
11	Tumor Selective Cytotoxic Action of a Thiomorpholin Hydroxamate Inhibitor (TMI-1) in Breast Cancer 2012 ·PLoS ONE ·(unknown), Carole Berruyer-Pouyet, Olivier Cabaud, Emmanuelle Josselin, Sébastien Combes, Jean Michel Brunel, Patrice Viens, Yves Collette, Daniel Birnbaum, Marc Lopez	6
12	Mevalonate Metabolism Regulates Basal Breast Cancer Stem Cells and Is a Potential Therapeutic Target 2012 ·Stem Cells ·Christophe Ginestier, Florence Monville, Julien Wicinski, Olivier Cabaud, Nathalie Cervera, Emmanuelle Josselin, Pascal Finetti, Arnaud Guillé, (unknown), Patrice Viens, Saı̈d M. Sebti, François Bertucci, Daniel Birnbaum, Emmanuelle Charafe‐Jauffret	124
13	Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth 2011 ·Oncogene ·Gilles Fournier, Olivier Cabaud, Emmanuelle Josselin, (unknown), José Adélaı̈de, Daniel Isnardon, Audrey Restouin, Rémy Castellano, Patrice Dubreuil, Max Chaffanet, Daniel Birnbaum, Marc Lopez	45
14	CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts breakdown → 2010 ·Journal of Clinical Investigation ·Christophe Ginestier, Suling Liu, Mark E. Diebel, Hasan Körkaya, Ming Luo, (unknown), Julien Wicinski, Olivier Cabaud, Emmanuelle Charafe‐Jauffret, Daniel Birnbaum, Jun-Lin Guan, Gabriela Dontu, Max S. Wicha	588
15	Duality of Enhancer Functioning Mode Revealed in a Reduced TCRβ Gene Enhancer Knockin Mouse Model 2009 ·The Journal of Immunology ·Marie Bonnet, Fang Huang, Touati Benoukraf, Olivier Cabaud, Christophe Verthuy, (unknown), Sébastien Jaeger, Pierre Ferrier, Salvatore Spicuglia	11
16	Cellules souches et cancers épithéliaux : l’exemple du cancer du sein 2008 ·Annales de Pathologie ·Emmanuelle Charafe‐Jauffret, Christophe Ginestier, Florence Monville, Julien Wicinski, François Bertucci, Patrice Viens, Luc Xerri, Olivier Cabaud, Gabriela Dontu, Max S. Wicha, Daniel Birnbaum	1
17	In Vivo Reinsertion of Excised Episomes by the V(D)J Recombinase: A Potential Threat to Genomic Stability 2007 ·PLoS Biology ·Katrina Vanura, Bertrand Montpellier, Trang Le, Salvatore Spicuglia, Jean‐Marc Navarro, Olivier Cabaud, Sandrine Roulland, (unknown), Immo Prinz, Pierre Ferrier, Rodrig Marculescu, Ulrich Jäger, Bertrand Nadel	23
18	Assessing the Role of the T Cell Receptor β Gene Enhancer in Regulating Coding Joint Formation during V(D)J Recombination 2003 ·Journal of Biological Chemistry ·N. Mathieu, Salvatore Spicuglia, (unknown), Olivier Cabaud, (unknown), Christophe Verthuy, William M. Hempel, Anne‐Odile Hueber, Pierre Ferrier	25
19	αβ T‐cell development is not affected by inversion of TCRβ gene enhancer sequences: polar enhancement of gene expression regardless of enhancer orientation 2003 ·Immunology ·Fang Huang, Olivier Cabaud, Christophe Verthuy, Anne‐Odile Hueber, Pierre Ferrier	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact